Featured News
AIM Blog
1,100 Advocates Turn Capitol Hill Purple During 2025 AIM Advocacy Forum
Last week, more than 1,100 advocates from all 50 states gathered together in Washington, D.C., for the 2025 AIM Advocacy Forum. Whether it was their first or 10th time attending, ad...
All News
Press Release
Alzheimer’s Association Welcomes U.S. FDA Approval of Kisunla (Donanemab)
CHICAGO, July 2, 2024 — The Alzheimer’s Association celebrates today’s U.S. Food and Drug Administration (FDA) action to approve Kisunla™...
AIM Blog
Congress Can Take Action During Alzheimer’s & Brain Awareness Month
The lifetime risk for Alzheimer's at age 45 is 1 in 5 for women and 1 in 10 for men...
AIM Blog
State Legislatures Take Action: Advancing Alzheimer’s Training for First Responders
Gloria Brown’s husband Arthur was diagnosed with Alzheimer’s in 2015. Two years later, while she was trying to get Arthur...
Press Release
Alzheimer’s Association Welcomes FDA Advisory Committee Unanimous Vote of Efficacy of Donanemab for the Treatment of Early Alzheimer’s Disease
CHICAGO, June 10, 2024 — The Alzheimer’s Association welcomes today’s U.S. Food and Drug Administration (FDA) advisory committee’s unanimous finding...
AIM Blog
Recognizing AIM’s June Advocate of the Month: John Mathis
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
Press Release
Senate HELP Committee Advances BOLD Legislation to Renew Nation’s Commitment to Dementia Public Health Infrastructure
Washington, D.C., May 23, 2024 — Today the Senate Committee on Health, Education, Labor and Pensions (HELP) overwhelmingly passed the...